BAX and non-small cell lung carcinoma: In a dose- and time-dependent manner, GA suppressed the growth and induction of non-small cell lung carcinoma (NSCLC) A549 cell line, which was linked to downregulated B-cell lymphoma 2 (Bcl-2) and increased (Bcl-2)-associated X protein (Bax) [212].